Procter & Gamble vs Solesence
Procter & Gamble (PG) and Solesence (SLSN) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $393B
- Last close
- $169.37
- 12 months
- +14.3%
- Market value
- $99.6M
- Last close
- $1.41
- 12 months
- −31.6%
At a glance
- The biggest part of Solesence's revenue is Consumer Products, 88% of the total in its last annual report.
- By market value, Procter & Gamble ($392.6B) is about 3941 times Solesence ($100M).
- Over the last 12 months Procter & Gamble's share price moved +14.3% and Solesence's −31.6%; against the S&P 500 that is +8.6 points and −37.3 points.
- In their last fiscal years Procter & Gamble kept 18.4% of revenue as net income and Solesence 4.5%.
- In the last 90 days insiders reported 0 open-market purchases at Procter & Gamble and 0 at Solesence; members of Congress disclosed 9 trades in Procter & Gamble and 0 in Solesence.
- Next results: Procter & Gamble Jan 20, 2027, Solesence not announced.
How each one makes money: Procter & Gamble revenue · Solesence revenue
Share prices on one chart
Procter & Gamble and Solesence, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Procter & Gamble PGNYSE · Personal Care Products | Solesence SLSNNASDAQ · Perfumes, Cosmetics & Other Toilet Preparations | |
|---|---|---|
| Size and profitability | ||
| Market value | $393B | $99.6M |
| Revenue, last fiscal year | $87B | $62.1M |
| Net income, last fiscal year | $16B | $2.81M |
| Net marginNet income as a share of revenue | 18.4% | 4.5% |
| Free cash flow | $15.1B | −$13.1M |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Procter & Gamble against
Common questions
How is Procter & Gamble different from Solesence?
Procter & Gamble (PG) is in Personal Care Products on NYSE, with $87B of revenue in its last fiscal year and a net margin of 18.4%. Solesence (SLSN) is in Perfumes, Cosmetics & Other Toilet Preparations on NASDAQ, with $62.1M of revenue in its last fiscal year and a net margin of 4.5%. The biggest part of Solesence's revenue is Consumer Products, 88% of the total in its last annual report. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Procter & Gamble and Solesence compare in size?
Procter & Gamble has the larger market value: Procter & Gamble $393B and Solesence $99.6M, at the last close.
Whose share price rose more over the last 12 months, PG or SLSN?
Over the last 12 months Procter & Gamble moved +14.3% and Solesence −31.6%. Past price moves say nothing about the future.
Which has had more insider buying, Procter & Gamble or Solesence?
Since 2006, Solesence insiders reported 738 open-market purchases against 21 for Procter & Gamble. These are counts of what was filed, not a view on either stock.
Do members of Congress trade PG or SLSN?
In the last 12 months, members of Congress disclosed 32 trades in Procter & Gamble (PG) and 0 in Solesence (SLSN).
When did insiders last buy PG and SLSN?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Procter & Gamble pageSolesence pageRare insider trades this weekAll comparisons
https://oqro.io/compare/pg-vs-slsn

